Abstract
A series of 2-substituted N-benzyl benzimidazole containing molecules has been synthesized and its structure–activity relationship for the human DP receptor has been evaluated. Selective DP antagonists with nanomolar potency for the DP receptor were identified in this novel series of benzimidazoles.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have